---
figid: PMC9384954__po-6-e2200135-g005
pmcid: PMC9384954
image_filename: po-6-e2200135-g005.jpg
figure_link: /pmc/articles/PMC9384954/figure/fig3/
number: FIG 3
figure_title: ''
caption: (A) PFS and (B) OS in patients with amplified ERBB2 according to log2-converted
  ERBB2 CN class. Overall survival according to (C) high/low CN (cutoff 16) and (D)
  with/without coamplification genes other than ERBB2 in the HER2 signaling pathway.
  CN, copy number; ERBB2, erb-b2 receptor tyrosine kinase 2; HER2, human epidermal
  growth factor receptor 2; OS, overall survival; PFS, progression-free survival.
article_title: Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab
  Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2â€“Positive Esophagogastric
  and Gastric Cancer.
citation: Kaori Hino, et al. JCO Precis Oncol. 2022;6:e2200135.
year: '2022'

doi: 10.1200/PO.22.00135
journal_title: JCO Precision Oncology
journal_nlm_ta: JCO Precis Oncol
publisher_name: Wolters Kluwer Health

keywords:
---
